We welcome interest from investors and are happy to provide more information on Elypta’s plans for development and commercialisation on request.

The academic research & development activities leading to the founding of Elypta was conducted at the Systems and Synthetic Biology division, Department of Biology and Biological Engineering at Chalmers University of Technology, Gothenburg, Sweden.

Commercialisation activities are in part financed by the Horizon 2020 programme of the European Union, Region Västra Götaland and SWElife, a strategic innovation programme funded by the Swedish Government via the Swedish innovation agency, Vinnova.

Chalmers Ventures is among Elypta’s early investors.


Investor jar.jpg